NEW YORK, May 12, 2023 /PRNewswire/ — Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Amgen Inc. (NASDAQ: AMGN). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/amgen-inc-lawsuit-submission-form/?id=39264&from=4 This lawsuit is on behalf of all persons who purchased or…Read More
AMGN Jakubowitz Law Reminds Amgen Shareholders of a Lead Plaintiff Deadline of May 12 2023 MarketScreener
